Cross-linked nanoparticles of silk fibroin with proanthocyanidins as a promising vehicle of indocyanine green for photo-thermal therapy of glioma
Source abstract
Abstract
Instability of silk fibroin nanoparticles (SFNPs) in physiologic condition hinders its application as drug delivery vehicle. Herein, indocyanine green (ICG) loaded silk fibroin nanoparticles (ICG-SFNPs) was firstly prepared and then crosslinked by proanthocyanidins to obtain the stable ICG-CSFNPs for killing the residual tumour niche under near infra-red irradiation (NIR) after surgery. The particle size and zeta potentials of ICG-CSFNPs was 120.1 nm and -40.4 mV, respectively. Moreover, ICG-CSFNPs exhibited good stability of particle size in the physiological medium. Meanwhile, the stable photothermal properties of ICG-CSFNPs were not compromised even after several cycles of NIR. Few of the ICG-CSFNPs were phagocytized by RAW264.7 macrophage in vitro, while they were easily internalized by C6 glioma cells, resulting in their significant toxicity on tumour cells after NIR. The pharmacokinetic study showed that ICG-CSFNPs had a longer blood circulation time than ICG-SFNPs, making them more distribution in glioma after intravenous administration in vivo. Meanwhile, the pharmacological study showed the more effective inhibition of tumour growth was exhibited by ICG-CSFNPs in C6 glioma-bearing mice after NIR. Overall, the cross-linked nanoparticles of silk fibroin may be a promising vehicle of ICG for photothermal therapy of glioma after surgical resection.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Silk-based biomaterials and applications · Nanoplatforms for cancer theranostics · RNA Interference and Gene Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Orthopaedics, The First Affiliated Hospital of Wenzhou Medical University
Department of Pharmaceutics, School of Pharmaceutical Sciences, Wenzhou Medical University
Department of Ultrasonography, The First Affiliated Hospital of Wenzhou Medical University
Funding
National Natural Science Foundation of China · Zhejiang Provincial Natural Science Foundation · Wenzhou Medical University
References (21)
Show source-provided references
1. 10.1007/s10143-016-0709-810.1007/s10143-016-0709-8 ↗
2. 10.2174/092986732466617051612320610.2174/0929867324666170516123206 ↗
3. 10.1038/s41467-018-02826-810.1038/s41467-018-02826-8 ↗
4. 10.1016/j.canlet.2010.12.01210.1016/j.canlet.2010.12.012 ↗
5. 10.1016/j.cej.2019.03.27210.1016/j.cej.2019.03.272 ↗
6. Andreas R, Jürgen B, Rüdiger G, et al. Near-infrared indocyanine green video angiography: a new method for intraoperative assessment of vascular flow. Neurosurgery. 2003;52:132–139.
7. 10.3390/nano806036010.3390/nano8060360 ↗
8. 10.2147/IJN.S12952610.2147/IJN.S129526 ↗
9. 10.1021/acsbiomaterials.8b0070510.1021/acsbiomaterials.8b00705 ↗
10. 10.1080/10717544.2018.142824410.1080/10717544.2018.1428244 ↗
11. 10.1016/j.carbpol.2016.12.04310.1016/j.carbpol.2016.12.043 ↗
12. Ye T, Xuejiao J, Xin C, et al. Doxorubicin-loaded magnetic silk fibroin nanoparticles for targeted therapy of multidrug-resistant cancer. Adv Mater. 2015;26:7393–7398.
13. 10.1016/j.biomaterials.2017.01.01910.1016/j.biomaterials.2017.01.019 ↗
14. 10.1016/j.lwt.2017.04.01110.1016/j.lwt.2017.04.011 ↗
15. 10.1016/j.ejpb.2012.05.00610.1016/j.ejpb.2012.05.006 ↗
16. 10.1016/j.ijpharm.2009.12.05210.1016/j.ijpharm.2009.12.052 ↗
17. 10.1016/j.biomaterials.2014.04.01910.1016/j.biomaterials.2014.04.019 ↗
18. 10.1016/j.biomaterials.2013.07.00710.1016/j.biomaterials.2013.07.007 ↗
19. 10.1016/j.actbio.2015.01.03910.1016/j.actbio.2015.01.039 ↗
20. 10.1016/j.jconrel.2014.12.01210.1016/j.jconrel.2014.12.012 ↗
21. 10.1016/j.biomaterials.2017.07.02710.1016/j.biomaterials.2017.07.027 ↗